| RS1554945033 |
WT1
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS1554945232 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS1554946437 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554946460 |
WT1
|
Health Risk |
Pathogenic |
— |
| RS1554946480 |
WT1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 4 |
| RS1554946500 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS1554946600 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS1554948134 |
HPS5
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 5, Hermansky-Pudlak syndrome 5 |
| RS1554948192 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554948302 |
HTRA1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1554948310 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554948318 |
HTRA1
|
Health Risk |
Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS1554948445 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554949176 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554949196 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554949242 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554950655 |
HTRA1
|
Health Risk |
Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS1554950703 |
HTRA1
|
Health Risk |
Pathogenic |
CARASIL syndrome, CARASIL syndrome |
| RS1554952193 |
EPS8L2
|
Health Risk |
Pathogenic |
Hearing loss, autosomal recessive 106 |
| RS1554952277 |
HTRA1
|
Health Risk |
Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS1554952291 |
HTRA1
|
Health Risk |
Pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS1554952443 |
EPS8L2
|
Health Risk |
Pathogenic |
Hearing loss, autosomal recessive 106 |
| RS1554952465 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554952467 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554952554 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554953745 |
USH1C
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 18A, Usher syndrome type 1C |
| RS1554953746 |
USH1C
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1C, Autosomal recessive nonsyndromic hearing loss 18A |
| RS1554954574 |
USH1C
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1C, Autosomal recessive nonsyndromic hearing loss 18A |
| RS1554954681 |
USH1C
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1C, Autosomal recessive nonsyndromic hearing loss 18A |
| RS1554954858 |
USH1C
|
Health Risk |
Likely pathogenic |
— |
| RS1554955952 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554956023 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1F, Usher syndrome type 1F |
| RS1554956088 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1F, Usher syndrome type 1F |
| RS1554958030 |
KCNQ1
|
Health Risk |
Likely pathogenic |
— |
| RS1554958043 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1554958045 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Jervell and Lange-Nielsen syndrome 1, Atrial fibrillation |
| RS1554958047 |
KCNQ1
|
Health Risk |
Likely pathogenic |
— |
| RS1554958049 |
KCNQ1
|
Health Risk |
Pathogenic |
— |
| RS1554958092 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Long QT syndrome 1, Long QT syndrome 1 |
| RS1554958132 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Cardiovascular phenotype |
| RS1554960388 |
USH1C
|
Health Risk |
Pathogenic |
Usher syndrome type 1C, Autosomal recessive nonsyndromic hearing loss 18A |
| RS1554960390 |
USH1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 1C, Autosomal recessive nonsyndromic hearing loss 18A |
| RS1554961118 |
NKX6-2
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic ataxia 8, autosomal recessive |
| RS1554961152 |
USH1C
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 18A, Usher syndrome type 1C |
| RS1554961872 |
USH1C
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1C, Autosomal recessive nonsyndromic hearing loss 18A |
| RS1554962286 |
CTSD
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1554963058 |
BEST1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Vitelliform macular dystrophy 2 |
| RS1554963095 |
BEST1
|
Health Risk |
Pathogenic |
Vitelliform macular dystrophy 2, Vitelliform macular dystrophy 2 |
| RS1554963305 |
BEST1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive bestrophinopathy, Retinal dystrophy |
| RS1554964287 |
BEST1
|
Health Risk |
Pathogenic |
Autosomal recessive bestrophinopathy, Autosomal recessive bestrophinopathy |
| RS1554965669 |
SLC25A22
|
Health Risk |
Pathogenic/Likely pathogenic |
Early myoclonic encephalopathy, Early-infantile DEE |
| RS1554965967 |
USH1C
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1C, Autosomal recessive nonsyndromic hearing loss 18A |
| RS1554966197 |
KCNMA1
|
Health Risk |
Pathogenic |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS1554967141 |
LRP5
|
Health Risk |
Pathogenic |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS1554967176 |
LRP5
|
Health Risk |
Pathogenic |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS1554967541 |
CSRP3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1M, Hypertrophic cardiomyopathy 12 |
| RS1554967575 |
COL13A1
|
Health Risk |
Pathogenic |
— |
| RS1554967681 |
SCYL1
|
Health Risk |
Pathogenic |
Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome, Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome |
| RS1554967761 |
SCYL1
|
Health Risk |
Pathogenic |
Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome, Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome |
| RS1554968138 |
CSRP3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1M, Hypertrophic cardiomyopathy 12 |
| RS1554968150 |
CSRP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS1554968726 |
B3GAT3
|
Health Risk |
Pathogenic/Likely pathogenic |
Larsen-like syndrome, B3GAT3 type |
| RS1554969688 |
PHF21A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554969894 |
SCYL1
|
Health Risk |
Likely pathogenic |
Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome, Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome |
| RS1554969925 |
SCYL1
|
Health Risk |
Pathogenic |
Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome, Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome |
| RS1554970010 |
TMEM138
|
Health Risk |
Pathogenic |
Joubert syndrome 16, Joubert syndrome 16 |
| RS1554970375 |
SCYL1
|
Health Risk |
Pathogenic |
Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome, Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome |
| RS1554971069 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS1554971145 |
LRP5
|
Health Risk |
Pathogenic |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS1554971742 |
LTBP3
|
Health Risk |
Pathogenic |
Geleophysic dysplasia 3, Geleophysic dysplasia 3 |
| RS1554972407 |
TMEM216
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Joubert syndrome |
| RS1554972547 |
TMEM216
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel syndrome |
| RS1554972556 |
TMEM216
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 2 |
| RS1554972958 |
TMEM216
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 2 |
| RS1554973844 |
LTBP3
|
Health Risk |
Pathogenic; confers sensitivity |
Brachyolmia-amelogenesis imperfecta syndrome, Heritable Thoracic Aortic Disease |
| RS1554975332 |
PNPLA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Neutral lipid storage myopathy |
| RS1554976234 |
ANO3
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Dystonia 24 |
| RS1554976504 |
SBF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1554977189 |
SBF2
|
Health Risk |
Pathogenic |
— |
| RS1554977547 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS1554981083 |
FGF3
|
Health Risk |
Pathogenic |
Deafness with labyrinthine aplasia, microtia |
| RS1554982237 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS1554982243 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS1554982299 |
PAX6
|
Health Risk |
Pathogenic |
Irido-corneo-trabecular dysgenesis, Aniridia 1 |
| RS1554982537 |
PAX6
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Aniridia 1 |
| RS1554982609 |
PAX6
|
Health Risk |
Pathogenic |
Irido-corneo-trabecular dysgenesis, Aniridia 1 |
| RS1554982615 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS1554982809 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS1554982824 |
ASS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia type I, Citrullinemia |
| RS1554982847 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS1554982914 |
BSCL2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1554983076 |
BSCL2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 2, Congenital generalized lipodystrophy type 2 |
| RS1554983140 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS1554983229 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1554983238 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS1554983251 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS1554983571 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1554983577 |
PAX6
|
Health Risk |
Pathogenic |
Irido-corneo-trabecular dysgenesis, Aniridia 1 |
| RS1554983586 |
PAX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1554983610 |
SDHAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |